Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
CORT

Market Cap: $12.19B

CI

Corcept Therapeutics Incorporated

CORT

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin98.30%

EBITDA Margin3.47%

EBIT Margin3.17%

Pre-tax Margin3.17%

Net Profit Margin6.61%

Earnings Yield0.46%

Valuation Multiples

Price / Book16.84

Price / Sales14.68

Price / Earnings216.90

PEG-3.69

Forward PEG2.00

EV / Sales14.55

EV / EBITDA419.98

EV / Operating Cash Flow110.22

EV / Free Cash Flow113.08

Price / Free Cash Flow114.03

Price / Operating Cash Flow108.35

Cash Flow & Capital

Free Cash Flow / Share$1.01

Operating Cash Flow / Share$1.04

Free Cash Flow Yield0.88%

Capex / Revenue0.33%

Capex / Operating Cash Flow2.53%

Capex / Depreciation1.15

Stock Compensation / Revenue-1.36%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.86

Quick Ratio2.77

Cash Ratio0.72

Debt / Assets0.01

Debt / Capital0.01

Debt / Equity0.01

Long-Term Debt / Capital0.01

Debt / Market Cap0.08%

Net Debt / EBITDA-3.53

Solvency Ratio0.31

Financial Leverage1.26

Efficiency & Working Capital

Asset Turnover0.93

Fixed Asset Turnover69.27

Inventory Turnover1.07

Receivables Turnover10.80

Payables Turnover0.94

Days Sales Outstanding33.79

Days Inventory Outstanding341.68

Days Payables Outstanding386.38

Operating Cycle375.47

Cash Conversion Cycle-10.91

Working Capital Turnover2.95

Returns & Quality

Return on Equity8.37%

Return on Assets6.18%

Return on Invested Capital0.87%

ROCE0.87%

Return on Tangible Assets6.18%

Operating Return on Assets0.75%

Income Quality0.85

Tax Burden2.08

Interest Burden1.00

Balance Sheet & Intrinsic Metrics

Enterprise Value$12.09B

Invested Capital$297.87M

Working Capital$285.87M

Tangible Asset Value$705.78M

Net Current Asset Value$256.75M

Graham Number$8.86

Graham Net-Net$1.8

Book Value / Share$6.7

Tangible Book Value / Share$6.7

Cash / Share$2.92

Financial Health Scores

Piotroski Score6

Altman Z-Score43.20

Revenue$830.81M

EBIT$26.37M

Market Cap$12.42B

Working Capital$285.87M

Retained Earnings$654.61M

Total Assets$888.7M

Total Liabilities$182.93M